Intensity Therapeutics, Inc. (INTS) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.83M | -2.4M | -2.39M | -2.46M | -1.99M | -2.67M | -3.97M | -4.21M | -4.37M | -947.17K | -5.12M | -238.91K |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 8.2% | 10.01% | 39.9% | 41.72% | 54.44% | -181.68% | 22.4% | -1663.82% | -384.57% | 42.06% | -399.04% | 82.08% |
| Net Income | -2.43M | -3.05M | -2.67M | -2.54M | -3.35M | -3.18M | -3.51M | -4.97M | -4.6M | -3.17M | -2.33M | -3.7M |
| Depreciation & Amortization | 7K | 6K | 6K | 0 | 6K | 0 | 7K | 6K | 6K | 5.89K | 2.02K | 38.62K |
| Stock-Based Compensation | 0 | 450K | 0 | 644K | 435K | 844K | 483K | 591K | 1.16M | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 387K | 1K | 471K | 7K | 0 | -102K | -1.68M | -38K | 0 | 422.74K | 351.17K | 2.72M |
| Working Capital Changes | 214K | 193K | -193K | -570K | 917K | -229K | 726K | 198K | -924K | 1.8M | -3.14M | 703.32K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | -138K | 104K | -472K | 866K | -568K | -896K | 643K | -1.45M | 1.88M | -1.22M | 682.37K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 3.1M | -6K | 3.26M | 2.82M | -8.84M | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 3.06M | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 150K | 7.25M | 7.24M | 3.74M | 328K | 2.48M | 413K | 3K | 8K | -12.16K | 20.52M | -241.83K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12.55K | 0 | 37.55K |
| Equity Issued (Net) | 150K | 7.25M | 7.24M | 3.74M | 328K | 3M | 413K | 3K | 8K | 348 | 20.52M | -279.34K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | -524K | 0 | 0 | 0 | 44 | 0 | -44 |
| Net Change in Cash | -1.68M | 4.85M | 4.85M | 1.29M | -1.66M | -192K | -459K | -4.22M | -1.1M | 1.86M | 6.56M | -480.74K |
| Free Cash Flow | -1.83M | -2.4M | -2.39M | -2.46M | -1.99M | -2.67M | -3.97M | -4.21M | -4.37M | -947.17K | -5.12M | -238.91K |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 8.2% | 10.01% | 39.9% | 41.72% | 54.44% | -181.68% | 22.4% | -1663.84% | -384.57% | 42.06% | -399.04% | 82.08% |
| FCF per Share | -0.07 | -0.18 | -1.39 | -3.25 | -3.28 | -4.63 | -7.19 | -7.68 | -7.96 | -1.72 | -9.37 | -1.70 |
| FCF Conversion (FCF/Net Income) | 0.75x | 0.79x | 0.89x | 0.97x | 0.59x | 0.84x | 1.13x | 0.85x | 0.95x | 0.30x | 2.20x | 0.06x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |